The impact of migraine on work, family, and leisure among young women – a multinational study

References

• Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646–57
   Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Eng J Med 2002;346:257–70
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia 2004;24\(suppl 1): 1–160
   Google Scholar
• Smith R. Impact of migraine on the family. Headache 1998;38:423–6
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003;23:429–40
   PubMed Web of Science ®Google Scholar
• Zelterman D. Advanced Log-Linear Models Using SAS. Cary, NC: SAS Publishing, 2002
   Google Scholar
• Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ 1992;2:103–15
   Google Scholar
• Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992;46:443–6
   Google Scholar
• van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FFH. Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics 1995;7:170–9
   PubMed Web of Science ®Google Scholar
• Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics 1998;13:667–76
   PubMed Web of Science ®Google Scholar
• Clarke CE, MacMillan L, Sondhi S, Wells NEJ. Economic and social impact of migraine. Q J Med 1996;89:77–84
   Google Scholar
• Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmaco-economics 1992;2:67–76
   Google Scholar
• Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 2001;19:197–206
   Google Scholar
• Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997;39:320–7
   Google Scholar
• Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998;38:87–96
   Google Scholar
• Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995;35:320–9
   PubMed Web of Science ®Google Scholar
• Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995;35:330–7
   PubMed Web of Science ®Google Scholar
• Burton WN, Morrison A, Wertheimer AI. Pharmaceuticals and worker productivity loss: a critical review of the literature. J Occup Environ Med 2003;45:610–21
   Google Scholar
• Davies GM, Santanello N, Gerth W, Lerner D, Block GA. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia 1999;19:497–502
   Google Scholar
• Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer MS. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia 2000;20:830–4
   PubMed Web of Science ®Google Scholar
• Cady RC, Ryan R, Jhingran P, O’Quinn S, Pait DG. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998;158:1013–8
   Google Scholar
• Schulman EA, Cady RK, Henry D, Batenhorst AS, Putnam DG, Watson CB, O’Quinn SO. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2000;75:782–9
   Google Scholar
• Larbig W, Brüggenjürgen B. Work productivity and resource consumption among migraineurs under current treatment and during treatment with sumatriptan – an economic evaluation of acute treatment in moderate to severe migraineurs. Headache Q 1997;8:237–46
   Web of Science ®Google Scholar
• Baos V, Serrano A, Torrecilla M, Bertral C, Caloto MT, Nocea G, et al. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting. Int J Clin Pract 2003;57:761–8
   PubMed Web of Science ®Google Scholar
• Gerth WC, Ruggles KH, Stark SR, Davies GM, Santanello NC. Improvement in health-related quality of life with rizatriptan 10mg compared with standard migraine therapy. Clin Drug Invest 2001;21: 853–60
   Google Scholar
• Legg RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost-effectiveness of sumatriptan in a managed care population. Am J Manag Care 1997;3:117–22
   PubMedGoogle Scholar
• Kuusela V. Telephone coverage in Finland. Statistics Finland, International Blaise Users Group. Available at http://www.blaiseusers.org/newsletters/bug11/fintel.htm [Accessed on 14 April 2004]
   Google Scholar
• Wunder P, Rapaport L. The Information Technology Landscape in Israel, Telecommunications Infrastructure. In: Information Technology Landscape in Nations Around the World, American University, Kogod School of Business; 2001. Available at http://www.american.edu/carmel/nk3791a/infrastructure.htm [Accessed on 14 April 2004]
   Google Scholar
• Facts about Information and Communications Technology in Sweden 2003. Schagerström T (ed.) Swedish Institute For Transport and Communications Analysis, 2003. Available at http://www.sika-institute.se/utgivning/ars_ikt03en_1.pdf [Accessed on 14 April 2004]
   Google Scholar
• Babbie E. The Practice of Social Research, 7th edn. Belmont, CA: Wadsworth Publishing Co, 1995
   Google Scholar
• Singleton RA, Straits BC, Straits MM. Approaches to Social Research, 2nd edn. New York, NY: Oxford University Press, 1993
   Google Scholar